Table 3.
Relationship between TYROBP levels and clinicopathological parameters of osteosarcoma.
| Variables | TYBOBP | χ2 | P value | |
|---|---|---|---|---|
| Low (%) | High (%) | |||
| Age (yr) | 0.083 | .773 | ||
| <18 | 31 (50.8) | 30 (49.2%) | ||
| ≥18 | 7 (46.7) | 8 (53.3%) | ||
| Gender | 0.213 | .645 | ||
| Female | 18 (52.9) | 16 (47.1%) | ||
| Male | 20 (47.6) | 22 (52.4%) | ||
| Metastasis status | 2.621 | .105 | ||
| Metastasis | 12 (66.7) | 6 (33.3%) | ||
| Non-metastasis | 26 (44.8) | 32 (55.2%) | ||
| Primary tumor site | 8.833 | .012 | ||
| Arm/hand | 4 (100.0) | 0 (0.0%) | ||
| Leg/foot | 32 (45.7) | 38 (54.3%) | ||
| Pelvis | 2 (100.0) | 0 (0.0%) |
TYROBP = TYRO protein tyrosine kinase-binding protein.